Your browser doesn't support javascript.
loading
Susac's syndrome as an immune-related adverse event after pembrolizumab: a case report.
De Groot, M; Compter, A; De Langen, A J; Brandsma, D.
Affiliation
  • De Groot M; Department of Neuro-Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, PO Box 90203, 1006 BE, Amsterdam, The Netherlands. ma.d.groot@nki.nl.
  • Compter A; Department of Neuro-Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, PO Box 90203, 1006 BE, Amsterdam, The Netherlands.
  • De Langen AJ; Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.
  • Brandsma D; Department of Neuro-Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, PO Box 90203, 1006 BE, Amsterdam, The Netherlands.
J Neurol ; 267(1): 282-284, 2020 Jan.
Article in En | MEDLINE | ID: mdl-31701330
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Susac Syndrome / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Lung Neoplasms Limits: Female / Humans / Middle aged Language: En Journal: J Neurol Year: 2020 Document type: Article Affiliation country: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Susac Syndrome / Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Lung Neoplasms Limits: Female / Humans / Middle aged Language: En Journal: J Neurol Year: 2020 Document type: Article Affiliation country: Países Bajos